OC tissue samples | ||
---|---|---|
OC patients (n) | 155 | |
Age at primary diagnosis | 59 (range 21–88) | |
Median age (a) | 10 (6.7) | |
< 40 (n, %) | 23 (15.3) | |
40–49 (n, %) | 61 (40.7) | |
50–65 (n, %) | 56 (37.3) | |
>65 (n, %) | ||
Histology (%) | serous | 70.5 |
mucinous | 13.5 | |
endometrioid | 7.7 | |
clear cell | 8.3 | |
Tumor grade (%) | low grade | 27.2 |
intermediate | 36.5 | |
high grade | 36.3 | |
Tumor stage (FIGO) (%) | I | 22.6 |
II | 5.8 | |
III | 70.3 | |
IV | 1.3 | |
Gonadotropin receptor expression (%)[34] | LH-R positive | 64.3 |
FSH-R positive | 63.1 | |
Oestrogen receptor expression (%) | ER-α positive | 31.4 |
ER-β positive | 60.1 | |
Progesterone receptor expression (%) | PR-A positive | 36.2 |
PR-B positive | 33.8 |